Navigation Links
New VSL#3® JUNIOR probiotic for children now available
Date:8/7/2012

GAITHERSBURG, MD, August 7, 2012 Sigma-Tau Pharmaceuticals, Inc., is excited to introduce a new probiotic medical food for children with IBS. A study published in the Journal of Pediatric Gastroenterology and Nutrition (1) , found that VSL#3, a high-potency probiotic medical food, provided a beneficial role in the dietary management of children who suffer from irritable bowel syndrome (IBS), a common problem for which there is no cure. This finding led Sigma-Tau, distributor of VSL#3, to develop and introduce new VSL#3 JUNIOR; a high-potency probiotic medical food for the dietary management of irritable bowel syndrome (IBS) and ulcerative colitis (UC) in children. New VSL#3 JUNIOR is now available through participating pharmacies behind the counter.

"One of the most obscure consequences of IBS in children is the way these conditions affect their entire family," expresses Mary Ocnean, senior product manager at Sigma-Tau Pharmaceuticals. "VSL#3 has been clinically proven to provide significant improvement in family life disruption scores and in reducing the discomfort and bloating of IBS. It is the first probiotic medical food that has been studied in a pediatric, randomized, double-blind, placebo-controlled crossover trial for children. It was a natural next step for us to extend the line of VSL#3 products with a pediatric version and we're happy to announce that it is now available to consumers in a once daily formulation," adds Ocnean.

Unlike other probiotics, VSL#3 JUNIOR is a medical food and requires refrigeration to preserve its 8 proprietary strains of 225 billion live bacteria, making it one of the few probiotics with this many strains and about 50 times more potent than the average probiotic (2) . VSL#3 JUNIOR is all-natural and comes in watermelon, a kid-pleasing flavor, making compliance less of an issue.

"There has been extensive clinical research in patients who added VSL#3 to their daily regimen, and the evidence shows that this probiotic plays a beneficial role in the dietary management of children suffering with IBS and UC (3) . IBS patients receiving VSL#3 also had significantly greater improvements versus both baseline and placebo in discomfort, bloating, gassiness and family assessment of life disruption (1). For young patients with UC, VSL#3 JUNIOR offers a tasty alternative to current VSL#3 products," says Ocnean. VSL#3 JUNIOR can be mixed into cold drinks, such as water and juice or foods like applesauce or ice cream, making it easy for children who find taking medication difficult. Adjustment of the intestinal flora can take a few days or weeks; it may take up to one month for the colonization of the gut to become optimally stable. All natural VSL#3 JUNIOR is gluten free, is Kosher and Halal certified, and a non-dairy product. Each box contains 30 watermelon flavored packets. As with all forms of VSL#3, they must be used under medical supervision.


'/>"/>
Contact: Nicole Egan
negan@rlapr.com
914-241-0086
Robin Leedy & Associates, Inc.
Source:Eurekalert

Related medicine news :

1. Probiotic Products May Prevent Antibiotic-Linked Diarrhea
2. Food hypersensitivity and otolaryngologic conditions in young children
3. Mothers, children underestimate obesity in China
4. Preschool children who can pay attention more likely to finish college
5. Adalimumab is a promising therapy for children with Crohns disease
6. Medical complications in hospitalized children: The Canadian Paediatric Adverse Events Study
7. Women and Children First? Not So, Says Study
8. Neglect May Harm Brain Growth in Children
9. Wayne State develops better understanding of memory retrieval between children and adults
10. Heavy Drinking in Pregnancy Linked to Host of Problems in Children
11. New lipid screening guidelines for children overly aggressive, UCSF researchers say
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... More than 20,000 pairs of ... Congo (DRC) thanks to an ambitious venture that conjoined the passions of an NBA ... support of the Liberty community. These shoes will save lives from the rampant infections ...
(Date:8/18/2017)... ... August 18, 2017 , ... Mediaplanet today announces the launch ... lifestyles and highlighting the importance of proactive eye and ear health. The campaign ... latest innovations in hearing aid technology. , In this issue, the National ...
(Date:8/18/2017)... , ... August 18, 2017 , ... ... handling handheld devices. Through an educational webinar, they will present the line of ... chance to learn how easy you can automate everyday pipetting tasks. , Ideal ...
(Date:8/18/2017)... ... 2017 , ... Radabaugh & Associates, a family managed agency ... West Virginia, is embarking on a cooperative charity effort with the Chestnut Mountain ... Chestnut Mountain Ranch (CMR) is a Christ-centered boarding school for young men offering ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Brian Gifford Agency, an ... is campaigning in support of Campagna Academy in a charity drive to provide for ... Boys’ Town of Indiana,” Campagna Academy is a nonprofit organization that has offered critical ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... AccuGenomics, Inc., a diagnostic company based in ... the company has provided an AccuKit to the HIV ... Chapel Hill and to Qura Therapeutics for evaluation in ... HIV reservoir and viral expression in human CD4+ T ... Center is a joint initiative between the University of ...
(Date:8/8/2017)... Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a ... reports its financial results for the second quarter ended ... the second quarter 2017 and to date: ... development programs for the Company,s lead project, BL-8040: ... study with BL-8040 as novel stem cell mobilization treatment ...
(Date:8/7/2017)... 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation,s largest ... June 30, 2017.  All comparisons, unless otherwise noted, are to ... Second Quarter 2017 Highlights include: ... an increase of 3.5% Total prescriptions dispensed ... of 7.5% versus 7.6% Gross profit ...
Breaking Medicine Technology: